ME Therapeutics Holdings Inc.

METXF·OTC Markets OTCPK·Healthcare
Compare
1.67000.0000 (0.00%)today
At close: Oct 19, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.6700
Open—
Day range—
52-week range1.67003.2500
Off day high—
Off 52-week high−48.62%
Volume—
Avg. volume (3M)28.00
Market cap50.18M
EPS (TTM)-0.0300
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)-0.01
Shares outstanding30.05M
Short interest—
Earnings dateJun 26, 2025 (est.)
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
METXF ONCY APLM CHRS HBP.TO BCTX
Market cap 50.18M 67.06M 62.94M 157.59M 74.85M 31.32M
P/E (TTM) — — — — — —
Forward P/E — -2.6 -33.2 -1.6 -8.9 -9.2
Price/book 112.2 -10.4 -14.5 2.6 5.1 1.1
Dividend yield — — — — — —
1-year change −43.34% −57.63% −24.45% −40.48% −59.17% −71.29%
Today 0.00% +2.57% −2.07% +2.00% 0.00% +4.05%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All METXF news ›
Investing News Network (INN)·

ME Therapeutics Extends Option Agreement for CD22 Nanobody Asset

ME Therapeutics Holdings Inc. a publicly listed biotechnology company working on novel cancer-fighting drugs in the field of immuno-oncology, today announced an extension to its option agreement to license the National Research Council of…

MarketScreener·Positive

ME Therapeutics Holdings Inc. : Insider Transactions

Follow insider transactions on ME Therapeutics Holdings Inc. in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions ME Therapeutics Holdings Inc. Biotechnology & Medical…

MarketScreener·Negative

ME Therapeutics Holdings Inc. Auditor Raises 'Going Concern' Doubt

ME Therapeutics Holdings Inc. filed its Annual on Nov 27, 2025 for the period ending Aug 31, 2025. In this report its auditor, Davidson & Company, gave an unqualified opinion expressing doubt that the... ME Therapeutics Holdings Inc.…

MarketScreener·

All Transcripts on ME Therapeutics Holdings Inc. (METX)

Find all the latest transcripts on ME Therapeutics Holdings Inc. Transcripts ME Therapeutics Holdings Inc. Biotechnology & Medical Research All financial news and data tailored to specific country editions

From articles in the 4Search news index.

In the news

16mentions in 30 days
16with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.